Fu-Ping Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fu-Ping Huang has a total of 227 co-authors. Here are the top co-authors by number of shared publications:
- He-Dong Bian
Key Laboratory of Chemistry and Engineering of Forest Products, State Ethnic Affairs Commission, Guangxi Key Laboratory of Chemistry and Engineering of Forest Products, Engineering Research Center of Low-Carbon and High-Quality Utilization of Forest Biomass, School of Chemistry and Chemical Engineering, Guangxi Minzu University, Nanning 530006, China
28 shared publications Hai-Ye Li
27 shared publicationsYe Tao
Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China, Guangxi Key Laboratory of Chemistry and Molecular Engineering of Medicinal Resources, Guangxi University Engineering Research Center for Chemistry of Characteristic Medicinal Resources, School of Chemistry and Pharmaceutical Sciences
18 shared publicationsDi Yao
12 shared publicationsPeng-Fei Yao
Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), School of Chemistry and Pharmacy, Guangxi Normal University, Guilin, Guangxi, P. R. China
12 shared publicationsQing Yu
School of Chemistry and Pharmacy, Guangxi Normal University, Guilin, People’s Republic of China
11 shared publications
Latest Publications
- 15 September 2026
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 55 (35) , 12848-12855
A triphenylphosphine-coordinated copper( i ) complex with aggregation-induced emission characteristics for chemodynamic therapy
Cu( i )-mediated Fenton-like catalytic performance has been extensively explored in chemodynamic therapy (CDT) due to its excellent reactive oxygen species (ROS) production.
- 15 September 2026
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 55 (35) , 12848-12855
A triphenylphosphine-coordinated copper( i ) complex with aggregation-induced emission characteristics for chemodynamic therapy
Cu( i )-mediated Fenton-like catalytic performance has been extensively explored in chemodynamic therapy (CDT) due to its excellent reactive oxygen species (ROS) production.
- 18 September 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (19) , 8100-8107
Post-Synthetic Modification of a Stepwise-Assembled [3 × 3] {Co9} Grid with Heterometallic Cd(II) and Homometallic Co(II) Salts
- 18 September 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (19) , 8100-8107
Post-Synthetic Modification of a Stepwise-Assembled [3 × 3] {Co9} Grid with Heterometallic Cd(II) and Homometallic Co(II) Salts
- 11 September 2025
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 64 (37) , 18950-18959
A Highly Stable Photoactivatable Pt(IV) Prodrug with Lower Dark Cytotoxicity for Photochemotherapy
Photoactivation of Pt(IV) prodrugs to Pt(II) species at tumor sites is a promising strategy to reduce systemic toxicity of platinum-based antitumor drugs. An ideal Pt(IV) prodrug should remain stable in the dark and be rapidly activated upon irradiation. However, existing photoactivatable Pt(IV) prodrugs, based on carboxylato ligands, are gradually reduced in the dark and require long irradiation times for photoactivation. In this study, we developed a photoactivatable Ru(II)-Pt(IV) complex, RuOPt, by conjugating a Ru(II) photosensitizer with an inert Pt(IV) moiety featuring an axial alkoxido ligand. Another complex, RuOOPt, with a carboxylato ligand, was also synthesized for comparison. RuOPt exhibited superior stability in the dark compared to RuOOPt. Both complexes were fully activated under 2 min of irradiation in the presence of ascorbate, releasing oxaliplatin. Additionally, both complexes underwent reduction and ligand substitution upon irradiation without electron donors. In cancer cell assays, the two Ru(II)-Pt(IV) complexes exhibited similar photocytotoxicity, while RuOPt showed up to 4.6 times lower dark cytotoxicity than RuOOPt and demonstrated reduced dark toxicity in colony formation, apoptosis, and tumor spheroid assays. This work provides a novel approach to enhance the stability and reduce dark cytotoxicity of photoactivatable Pt(IV) prodrugs using an axial alkoxido ligand.
- 11 September 2025
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 64 (37) , 18950-18959
A Highly Stable Photoactivatable Pt(IV) Prodrug with Lower Dark Cytotoxicity for Photochemotherapy
Photoactivation of Pt(IV) prodrugs to Pt(II) species at tumor sites is a promising strategy to reduce systemic toxicity of platinum-based antitumor drugs. An ideal Pt(IV) prodrug should remain stable in the dark and be rapidly activated upon irradiation. However, existing photoactivatable Pt(IV) prodrugs, based on carboxylato ligands, are gradually reduced in the dark and require long irradiation times for photoactivation. In this study, we developed a photoactivatable Ru(II)-Pt(IV) complex, RuOPt, by conjugating a Ru(II) photosensitizer with an inert Pt(IV) moiety featuring an axial alkoxido ligand. Another complex, RuOOPt, with a carboxylato ligand, was also synthesized for comparison. RuOPt exhibited superior stability in the dark compared to RuOOPt. Both complexes were fully activated under 2 min of irradiation in the presence of ascorbate, releasing oxaliplatin. Additionally, both complexes underwent reduction and ligand substitution upon irradiation without electron donors. In cancer cell assays, the two Ru(II)-Pt(IV) complexes exhibited similar photocytotoxicity, while RuOPt showed up to 4.6 times lower dark cytotoxicity than RuOOPt and demonstrated reduced dark toxicity in colony formation, apoptosis, and tumor spheroid assays. This work provides a novel approach to enhance the stability and reduce dark cytotoxicity of photoactivatable Pt(IV) prodrugs using an axial alkoxido ligand.
- 19 June 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1345
A Fenton-like catalyst for chemodynamic therapy in a Cu10L8 metal-organic cage with exchangeable anions
- 19 June 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1345
A Fenton-like catalyst for chemodynamic therapy in a Cu10L8 metal-organic cage with exchangeable anions
- 21 May 2025
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 27 (27) , 4634-4641
Subcomponent self-assembly approach in molecular cages and its implication on solution behavior
The subcomponent self-assembly approach for molecular cages had been summarized. Mass spectrometry technology is promising for analyzing the solution behavior and monitoring the formation process of such sophisticated aggregations.
- 21 May 2025
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 27 (27) , 4634-4641
Subcomponent self-assembly approach in molecular cages and its implication on solution behavior
The subcomponent self-assembly approach for molecular cages had been summarized. Mass spectrometry technology is promising for analyzing the solution behavior and monitoring the formation process of such sophisticated aggregations.
- 2 May 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (10) , 3548-3554
Thermotropic Approach from {Mn4} Cluster to One-Dimensional Coordination Polymer: Structure Conversion and Enhanced Magnetocaloric Effect
- 2 May 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (10) , 3548-3554
Thermotropic Approach from {Mn4} Cluster to One-Dimensional Coordination Polymer: Structure Conversion and Enhanced Magnetocaloric Effect
- 21 January 2025
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 27 (9) , 1307-1314
A 3D rigid Mn-MOF heterogeneous catalyst for thioether oxidation, cyanosilylation and Knoevenagel condensation
Metal–organic frameworks (MOFs) have attracted more and more attention in the field of heterogeneous catalytic materials due to their rich active sites and porosity. Under solvothermal conditions, 3D MOF{[Mn2(b-6-mpbt)(HCOO)2]·1.5CH3OH}n (1) (H2b-6-mpbt = 5,5′-bis(6-methylpyridin-2-yl)-1H,2′H-3,3′-bis(1,2,4-triazole)) and its bulk particles (1′) were successfully synthesized. 1′ exhibits excellent thermal stability and chemical stability, and has good catalytic potential as a heterogeneous catalyst in the thioether oxidation reaction, cyanosilylation reactions and Knoevenagel condensation reaction. More importantly, 1′ can be recycled for 5 reaction cycles as a heterogeneous catalyst, and the activity does not decrease significantly. These findings not only pave the way for the construction of nanoporous MOFs, but also prove the application prospect of Mn-MOFs with multiple catalytic activities.
- 21 January 2025
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 27 (9) , 1307-1314
A 3D rigid Mn-MOF heterogeneous catalyst for thioether oxidation, cyanosilylation and Knoevenagel condensation
Metal–organic frameworks (MOFs) have attracted more and more attention in the field of heterogeneous catalytic materials due to their rich active sites and porosity. Under solvothermal conditions, 3D MOF{[Mn2(b-6-mpbt)(HCOO)2]·1.5CH3OH}n (1) (H2b-6-mpbt = 5,5′-bis(6-methylpyridin-2-yl)-1H,2′H-3,3′-bis(1,2,4-triazole)) and its bulk particles (1′) were successfully synthesized. 1′ exhibits excellent thermal stability and chemical stability, and has good catalytic potential as a heterogeneous catalyst in the thioether oxidation reaction, cyanosilylation reactions and Knoevenagel condensation reaction. More importantly, 1′ can be recycled for 5 reaction cycles as a heterogeneous catalyst, and the activity does not decrease significantly. These findings not only pave the way for the construction of nanoporous MOFs, but also prove the application prospect of Mn-MOFs with multiple catalytic activities.
- 14 January 2025
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (2)
Two Ferrocene‐Modified Copper(I) Complexes for the Synergistic Enhancement of Chemodynamic Therapy
In recent years, some Cu‐based complexes and nanomaterials that can better adapt to tumour microenvironments and produce better chemodynamic therapeutic effects have been synthesised. Ferrocene and its derivatives have garnered increasing attention as a therapeutic option in chemodynamic therapy owing to their excellent catalytic activity. Herein, two ferrocene‐modified Cu(I) complexes, Fc‐ AD ‐Cu and Fc‐IH‐Cu , were synthesised with atomically precise structures. Both exhibit good Fenton/Fenton‐like activity, inducing the generation of reactive oxygen species in Hep‐G2 cells and improving chemodynamic therapeutic efficiency.
- 14 January 2025
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (2)
Two Ferrocene‐Modified Copper(I) Complexes for the Synergistic Enhancement of Chemodynamic Therapy
In recent years, some Cu‐based complexes and nanomaterials that can better adapt to tumour microenvironments and produce better chemodynamic therapeutic effects have been synthesised. Ferrocene and its derivatives have garnered increasing attention as a therapeutic option in chemodynamic therapy owing to their excellent catalytic activity. Herein, two ferrocene‐modified Cu(I) complexes, Fc‐ AD ‐Cu and Fc‐IH‐Cu , were synthesised with atomically precise structures. Both exhibit good Fenton/Fenton‐like activity, inducing the generation of reactive oxygen species in Hep‐G2 cells and improving chemodynamic therapeutic efficiency.
- 13 December 2024
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 63 (52) , 24771-24777
Construction and Magnetic Difference of {CoIIICoII12MII6} (M = CoII/CdII) Aggregates with Homo- and Heterometallic Centers Derived from {Co14} Precursors
Controllable synthesis of sophisticated aggregations has attracted wide attention from scientists. In this work, homo- and heterometallic {CoIIICoII12MII6} (M = CoII/CdII) aggregates with similar skeletons, composed of two [Co3M3(dpbt)3] peripheries and a central [Co7(OH)8] vertex-fused double-cubane, were constructed from prefabricated {Co14} clusters and characterized by single-crystal X-ray diffraction and XPS, ICP-MS, SEM (EDX), and so on. And then, the structure and magnetic differences of them had been further analyzed under dotted with paramagnetic CoII ions and/or diamagnetic CdII ions. Interestingly, the spin canting behavior in {CoIIICoII18} was suppressed in {CoIIICoII12CdII6}, upon the introducing of CdII ions.
- 13 December 2024
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 63 (52) , 24771-24777
Construction and Magnetic Difference of {CoIIICoII12MII6} (M = CoII/CdII) Aggregates with Homo- and Heterometallic Centers Derived from {Co14} Precursors
Controllable synthesis of sophisticated aggregations has attracted wide attention from scientists. In this work, homo- and heterometallic {CoIIICoII12MII6} (M = CoII/CdII) aggregates with similar skeletons, composed of two [Co3M3(dpbt)3] peripheries and a central [Co7(OH)8] vertex-fused double-cubane, were constructed from prefabricated {Co14} clusters and characterized by single-crystal X-ray diffraction and XPS, ICP-MS, SEM (EDX), and so on. And then, the structure and magnetic differences of them had been further analyzed under dotted with paramagnetic CoII ions and/or diamagnetic CdII ions. Interestingly, the spin canting behavior in {CoIIICoII18} was suppressed in {CoIIICoII12CdII6}, upon the introducing of CdII ions.